HMGB-1 as a Target for Inflammation Controlling

E-ISSN： 2212-3334|6|3|201-209

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.6, Iss.3, 2012-09, pp. : 201-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 35-45

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1 and Carbon Monoxide: Emerging Therapeutic Targets in Inflammation and Allergy

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 3, 2008-11 ,pp. : 159-165

Bentham Science Publishers

Access to resources Recommend Favorite

Allergic Inflammation and the Oral Mucosa

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 1, 2007-02 ,pp. : 35-38

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals to Prevent Inflammation and Allergy

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 147-158

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Delivery Systems for Controlling Diabetes

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 1, 2007-02 ,pp. : 25-40

Bentham Science Publishers

Access to resources Recommend Favorite